Evodiamine activates autophagy as a cytoprotective response in murine Lewis lung carcinoma cells

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 481-490

  Tu, Yong Jiu ^a,b   Fan, Xia ^a   Yang, Xue ^a   Zhang, Chun ^a   Liang, Hua Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b The Affiliated Chenggong Hospital of Xiamen University   (China)

Author keywords

Apoptosis; Autophagy; Evodiamine; Lewis lung carcinoma

Indexed keywords

3 METHYLADENINE; EVODIAMINE; MICROTUBULE ASSOCIATED PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; AUTOPHAGY SPECIFIC GENE; CARCINOMA CELL; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ADENINE; ANIMALS; APOPTOSIS; AUTOPHAGY; CARCINOMA, LEWIS LUNG; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; MICE; MICROTUBULE-ASSOCIATED PROTEINS; QUINAZOLINES; UP-REGULATION;

EID: 84872781914     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2125     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008. (Pubitemid 351521864)
2. Petty RD, Nicolson MC, Kerr K M, et al: Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res 10: 3237-3248, 2004. (Pubitemid 38685427)
3. Erridge SC, Moller H, Price A, et al: International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol 4: 570-577, 2007. (Pubitemid 47534756)
4. Wang TY, Wu JB, Hwang TL, et al: A new quinolone and other constituents from the fruits of Tetradium ruticarpum: effects on neutrophil pro-inflammatory responses. Chem Biodivers 7: 1828-1834, 2010.
5. Liu YN, Pan SL, Liao CH, et al: Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7. Shock 32: 263-269, 2009.
6. Wang T, Wang Y and Yamashita H: Evodiamine inhibits adipogenesis via the EGFR-PKCalpha-ERK signaling pathway. FEBS Lett 583: 3655-3659, 2009.
7. Wu CL, Hung CR, Chang FY, et al: Effects of evodiamine on gastrointestinal motility in male rats. Eur J Pharmacol 457: 169-176, 2002.
8. Zhang C, Fan X, Xu X, et al: Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells. Anticancer Drugs 21: 766-776, 2010.
9. Yang J, Wu LJ, Tashino S, et al: Protein tyrosine kinase pathway-derived ROS/NO productions contribute to G2/M cell cycle arrest in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res 44: 792-802, 2010
10. Wang C, Li S and Wang MW: Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicol In Vitro 24: 898-904, 2011.
11. Chen MC, Yu CH, Wang SW, et al: Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J Cell Biochem 110: 1495-1503, 2011.
12. Wang XN, Han X, Xu LN, et al: Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine 15: 1062-1068, 2008.
13. Kan SF, Yu CH, Pu HF, et al: Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J Cell Biochem 101: 44-56, 2007.
14. Ogasawara M, Matsunaga T, Takahashi S, et al: Anti-invasive and metastatic activities of evodiamine. Biol Pharm Bull 25: 1491-1493, 2002. (Pubitemid 39663174)
15. Meijer AJ and Codogno P: Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 36: 2445-2462, 2004. (Pubitemid 39119758)
16. Yang YP, Liang ZQ, Gao B, et al: Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells. Acta Pharmacol Sin 29: 123-134, 2008.
17. Ogier-Denis E and Codogno P: Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 1603: 113-128, 2003. (Pubitemid 36266686)
18. Liu D, Yang Y and Liu Q: Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol 28: 105-111, 2011.
19. Longo L, Platini F, Scardino A, et al: Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma. Mol Cancer Ther 7: 2476-2485, 2008.
20. Li J, Hou N, Faried A, et al: Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16: 761-771, 2009.
21. Li J, Hou N, Faried A, et al: Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur J Cancer 46: 1900-1909, 2010.
22. Yang J, Wu LJ, Tashino S, et al: Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res 42: 492-504, 2008. (Pubitemid 351935163)
23. Lowe SW and Lin AWA: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000. (Pubitemid 30137934)
24. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007. (Pubitemid 46911891)
25. Van Gurp M, Festjens N, Van Loo G, et al: Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304: 487-497, 2003. (Pubitemid 36506521)
26. Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004. (Pubitemid 38456176)
27. Kuma A, Mizushima N, Ishihara N, et al: Formation of the approximately 350-kDa Apg12-Apg5.Apg16 multimeric complex, mediated by Apg16 oligomerization, is essential for autophagy in yeast. J Biol Chem 277: 18619-18625, 2002. (Pubitemid 34952416)
28. Fujita N, Itoh T, Omori H, et al: The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell 19: 2092-2100, 2008.
29. Kabeya Y, Mizushima N, Ueno T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
30. Hemelaar J, Lelyveld VS, Kessler BM and Ploegh HL: A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L. J Biol Chem 278: 51841-51850, 2003. (Pubitemid 38020431)
31. Suzuki K, Kirisako T, Kamada Y, et al: The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J 20: 5971-5981, 2001. (Pubitemid 33049272)
32. Mizushima N, Yamamoto A, Hatano M, et al: Dissection of auto phagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 152: 657-668, 2001.
33. Seglen PO and Gordon PB: 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 79: 1889-1892, 1982. (Pubitemid 12088533)
34. Petiot A, Ogier-Denis E and Blommaart EF: Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 275: 992-998, 2000. (Pubitemid 30051145)
35. Maiuri MC, Criollo A and Kroemer G: Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J 29: 515-516, 2010.
36. Gozuacik D and Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004. (Pubitemid 38638851)
37. Laane E, Tamm K P, Buentke E, et al: Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ 16: 1018-1029, 2009.
38. Herman-Antosiewicz A, Johnson DE and Singh SV: Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res 66: 5828-5835, 2006. (Pubitemid 43927137)
39. Aoki H, Takada Y, Kondo S, et al: Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72: 29-39, 2007. (Pubitemid 46998522)
40. Cui Q, Tashiro S, Onodera S, et al: Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol Pharm Bull 30: 859-864, 2007. (Pubitemid 46708626)
41. Wu YC, Wu WK, Li Y, et al: Inhibition of macroautophagy by bafilomycin A1 lowers proliferation and induces apoptosis in colon cancer cells. Biochem Biophys Res Commun 382: 451-456, 2009.
42. Hsu KF, Wu CL, Huang SC, et al: Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells. Autophagy 5: 451-460, 2009.
43. Eisenberg-Lerner A, Bialik S, Simon HU, et al: Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16: 966-975, 2009.
44. Ito S, Koshikawa N, Mochizuki S, et al: 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol 31: 261-268, 2007.
45. Goswami A, Ranganathan P and Rangnekar VM: The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target. Cancer Res 66: 2889-2892, 2006.
46. Opipari AW Jr, Tan L, Boitano AE, et al: Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64: 696-703, 2004. (Pubitemid 38120912)
47. Trincheri N F, Follo C, Nicotra G, et al: Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis 29: 381-389, 2008. (Pubitemid 351359678)